Back
Recursion Pharmaceuticals Stock Price Chart
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
RXRX
Recursion Pharmaceuticals
Last Price:
6.81
Seasonality Move:
-13.67%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is relatively stagnant and RXRX is experiencing selling pressure, which indicates risk of future bearish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.64 | Buy |
| 20-day SMA: | 6.81 | Buy |
| 50-day SMA: | 7.19 | Sell |
| 200-day SMA: | 9.05 | Sell |
| 8-day EMA: | 6.7 | Buy |
| 20-day EMA: | 6.74 | Buy |
| 50-day EMA: | 7.15 | Sell |
| 200-day EMA: | 8.29 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 51.91 | Buy |
| Chaikin Money Flow: | -3306494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.29 - 7.43) | Buy |
| Bollinger Bands (100): | (6.87 - 9.03) | Sell |
Recursion Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.93 while RXRX 8-day simple moving average is 6.64, which is a Buy signal.
- The stock price of RXRX is 6.93 while Recursion Pharmaceuticals 20-day SMA is 6.81, which makes it a Buy.
- Recursion Pharmaceuticals 50-day simple moving average is 7.19 while RXRX share price is 6.93, making it a Sell technically.
- RXRX stock price is 6.93 and Recursion Pharmaceuticals 200-day simple moving average is 9.05, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
46
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Sell
The current Recursion Pharmaceuticals [RXRX] share price is $6.93. The Score for RXRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.96B
Price in USD:
6.93
Share Volume:
4.02M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
4.97
Sell
46
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 6.93 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.93 while RXRX 8-day exponential moving average is 6.70, which is a Buy signal.
- The stock price of RXRX is 6.93 while Recursion Pharmaceuticals 20-day EMA is 6.74, which makes it a Buy.
- Recursion Pharmaceuticals 50-day exponential moving average is 7.15 while RXRX share price is 6.93, making it a Sell technically.
- RXRX stock price is 6.93 and Recursion Pharmaceuticals 200-day simple moving average is 8.29, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.09 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Recursion Pharmaceuticals is a Sell
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 51.91, which suggest Recursion Pharmaceuticals is overbought
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.29 - 7.43), which suggest Recursion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.87 - 9.03), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.